Balance Sheet
Cash Flow Statement
AcquisitionsAsset Writedowns and ImpairmentAsset Writedowns and ImpairmentCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Account PayablesChange in Account PayablesChange in Accured ExpensesChange in Accured ExpensesChange in CashChange in InventoryChange in InventoryChange in ReceivablesChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Depreciation & Amortization (CF)Dividends Paid - CommonDividends Paid - CommonFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesGains from Sales and DivestituresGains from Sales and DivestituresLong-Term Debt IssuancesLong-Term Debt RepaymentsNet Cash FlowNet Cash FlowNet IncomeOther Working Capital ChangesOther Working Capital ChangesOther financing activitiesOther financing activitiesSales of Property, Plant and EquipmentSales of Property, Plant and EquipmentShare-based CompensationShare-based CompensationShares Repurchased
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Core Laboratories (CLB) Gains from Sales and Divestitures (2023 - 2025)

Core Laboratories' Gains from Sales and Divestitures history spans 3 years, with the latest figure at $463244.0 for Q4 2025.

  • For Q4 2025, Gains from Sales and Divestitures rose 80.44% year-over-year to $463244.0; the TTM value through Dec 2025 reached $463244.0, up 80.44%, while the annual FY2025 figure was $463244.0, 80.44% up from the prior year.
  • Gains from Sales and Divestitures reached $463244.0 in Q4 2025 per CLB's latest filing, up from $256724.0 in the prior quarter.
  • In the past five years, Gains from Sales and Divestitures ranged from a high of $463244.0 in Q4 2025 to a low of $256724.0 in Q4 2024.
  • Average Gains from Sales and Divestitures over 3 years is $352270.7, with a median of $336844.0 recorded in 2023.
  • Peak YoY movement for Gains from Sales and Divestitures: dropped 23.79% in 2024, then skyrocketed 80.44% in 2025.
  • A 3-year view of Gains from Sales and Divestitures shows it stood at $336844.0 in 2023, then decreased by 23.79% to $256724.0 in 2024, then surged by 80.44% to $463244.0 in 2025.
  • Per Business Quant, the three most recent readings for CLB's Gains from Sales and Divestitures are $463244.0 (Q4 2025), $256724.0 (Q4 2024), and $336844.0 (Q4 2023).